Aby J. Mathew Biolife Solutions Inc (BLFS) insider trading activity

Aby J. Mathew is EVP & Chief Scientific Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 283,919 shares of BLFS, which is worth approximately $7.44 Million. The most recent transaction as insider was on Feb 03, 2022, when has been sold 9,837 shares (Common Stock) at a price of $27.76 per share, resulting in proceeds of $273,075. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 284K

10.73% 3M change

2.33% 12M change

Total Value Held $7.44 Million

Aby J. Mathew Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 03 2022	SELL Open market or private sale	$273,075 $27.76 p/Share	9,837 Reduced 4.56%	206,014 Common Stock
Feb 03 2022	BUY Exercise of conversion of derivative security	$20,264 $2.06 p/Share	9,837 Added 4.36%	215,851 Common Stock
Feb 02 2022	SELL Open market or private sale	$298,800 $29.88 p/Share	10,000 Reduced 4.63%	206,014 Common Stock
Feb 02 2022	BUY Exercise of conversion of derivative security	$37,000 $3.7 p/Share	10,000 Added 4.42%	216,014 Common Stock
Jan 05 2022	SELL Open market or private sale	$269,495 $34.3 p/Share	7,857 Reduced 3.67%	206,014 Common Stock
Jan 05 2022	BUY Exercise of conversion of derivative security	$11,000 $1.4 p/Share	7,857 Added 3.54%	213,871 Common Stock
Jan 04 2022	SELL Open market or private sale	$350,600 $35.06 p/Share	10,000 Reduced 4.63%	206,014 Common Stock
Jan 04 2022	BUY Exercise of conversion of derivative security	$14,000 $1.4 p/Share	10,000 Added 4.42%	216,014 Common Stock
Dec 29 2021	SELL Open market or private sale	$28,976 $39.37 p/Share	736 Reduced 0.36%	206,014 Common Stock
Dec 08 2021	SELL Open market or private sale	$323,046 $36.49 p/Share	8,853 Reduced 4.11%	206,750 Common Stock
Dec 08 2021	BUY Exercise of conversion of derivative security	$14,519 $1.64 p/Share	8,853 Added 3.94%	215,603 Common Stock
Dec 06 2021	SELL Open market or private sale	$343,900 $34.39 p/Share	10,000 Reduced 4.61%	206,750 Common Stock
Dec 06 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.41%	216,750 Common Stock
Nov 30 2021	BUY Open market or private sale	$16,840 $37.59 p/Share	448 Added 0.22%	206,750 Common Stock
Nov 17 2021	SELL Open market or private sale	$510,700 $51.07 p/Share	10,000 Reduced 4.6%	207,198 Common Stock
Nov 17 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.4%	217,198 Common Stock
Nov 15 2021	SELL Open market or private sale	$481,100 $48.11 p/Share	10,000 Reduced 4.6%	207,198 Common Stock
Nov 15 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.4%	217,198 Common Stock
Oct 20 2021	SELL Open market or private sale	$419,700 $41.97 p/Share	10,000 Reduced 4.6%	207,198 Common Stock
Oct 20 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.4%	217,198 Common Stock
Oct 18 2021	SELL Open market or private sale	$413,400 $41.34 p/Share	10,000 Reduced 4.6%	207,198 Common Stock
Oct 18 2021	BUY Exercise of conversion of derivative security	$16,400 $1.64 p/Share	10,000 Added 4.4%	217,198 Common Stock
Oct 14 2021	SELL Open market or private sale	$50,882 $39.97 p/Share	1,273 Reduced 0.61%	207,198 Common Stock
Sep 28 2021	SELL Open market or private sale	$31,003 $43.12 p/Share	719 Reduced 0.34%	208,471 Common Stock
Sep 22 2021	SELL Open market or private sale	$469,900 $46.99 p/Share	10,000 Reduced 4.56%	209,190 Common Stock

AJM

Aby J. Mathew

EVP & Chief Scientific Officer

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Value

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS

Account